AstraZeneca shares rise as fresh reports deny mega-merger talks with US rival
Summary
Astra's stock climbed 2.5% or 296p to 12,036p after Reuters quoted a senior source at the business quashing rumours of any potential tie-up. AstraZeneca shares rose following reports that there had been ‘no discussions’ about a potential mega-merger with a US rival.